Skip to main content
Caplight Logo









PerturbAI

PerturbAI

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.perturb.ai/

Last Round

Pre Seed

Sep 1, 2025

Company Overview

PerturbAI is a biotechnology company that develops an AI-enabled drug discovery platform by combining large-scale in vivo CRISPR perturbation with artificial intelligence to map causal biological relationships.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Foundation

Keywords

drug discoveryCRISPRfunctional genomicsbiological foundation modelscausal inferencein vivo CRISPRtarget identificationsingle-nucleus RNA sequencingAI-native therapeuticsgenomic datain silico drug discoverydata as a serviceDaaSprecision medicinebio-ML

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PerturbAI Comparables

Compare PerturbAI with similar companies based on industry and business-model similarity.

PerturbAI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Synlico Inc.
87%
Algen Biotechnologies
84%
Myllia Biotechnology
84%

PerturbAI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedSep 1, 2025

Key People

Founding team and executive leadership

Grace Zheng

Chief Executive Officer & Co-Founder

Founding Team

Caroline Moon

Consulting COO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2025

    Completed a Pre Seed funding round.

Recent news

Latest coverage and updates

  • is_developingJun 23, 2026

    Perturb is developing tools to accelerate therapeutic design workflows on Jun 23rd '26.

PerturbAI Filings

Explore SEC and related filing metadata, where available.

PerturbAI filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PerturbAI's valuation, stock price, and market status.

Is PerturbAI a public or private company?

PerturbAI is a private company.

What is the current stock price of PerturbAI?

PerturbAI is a private company with no public stock price. Caplight tracks PerturbAI's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is PerturbAI worth (valuation)?

Valuation information for PerturbAI is not publicly available.

Can I buy PerturbAI stock?

PerturbAI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PerturbAI's last funding round?

PerturbAI's most recent funding round was Pre Seed on September 1, 2025.

Who are the main investors in PerturbAI?

Investor information for PerturbAI is not publicly disclosed.

Will PerturbAI IPO soon?

No public IPO plans have been announced for PerturbAI.

How can I track PerturbAI secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PerturbAI's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range4
Year Founded2025
Last FundingSep 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?